UK Oncology Forum

Dear Colleague

Unfortunately, the ACP has now had to cancel the Town Hall meeting, scheduled at the forthcoming UK Oncology Forum. The committee apologise for any inconvenience caused.

However – the UK Oncology Forum Faculty is excited to inform you that the meeting has been replaced with a new and very interesting Rapid Diagnostic Services Session, chaired by Dr Saoirse Dolly.

The UK Oncology forum is proud to showcase this inaugural meeting – highlighting the Rapid Diagnostic Services (RDS) for patients with non-site specific symptoms (NSS). Patients with NSS (such as weight loss, fatigue or pain) generally do not fit the standard two week rule (2WW) referral criteria and often bounce around systems and take longer to get diagnosed and treated.

Rapid Diagnostic Clinics (RDCs) provide a NSS 2WW referral route. These are being expanded across the Country with the aim of providing personalised, coordinated diagnostics to facilitate earlier cancer diagnosis and fast-track care. As well as reducing geographic differences in access to diagnostics. This session aims to bring primary care, diagnosticians, oncologists, radiologists and nurse practitioners together to share experiences in the development of the RDS and combine thinking on future developments and innovation.

Potential themes include:
1. RDS overview
RDC referral processes, filter function tests, pathway, alignment with cancer waiting times.
Clinical outcomes (present SEL RDC paper) with a focus on elderly, medically complex patients and mental health.
2. The RDS/re-direct
The vision – one referral, fluidity of care and improved patient journey. Process of re-directing patients between NSS and site specific (SS) pathways.
Options of front and back end redirects from other pathways
Present SEL data on volume of re-referrals from SS 2WW pathways and evaluation of the SEL lower GI back end pathway
Different models – ? involve greater manchester team where they use the upfront re-directs. Ernie on the AOS focused RDC model
3. Sustainability and service expansion
Overcoming health inequalities, NHSE typologies, workforce, financial effectiveness of the service
4. Innovation
Research opportunities, development, clinical trials

The session will take place Thursday 16th June 10:30hrs – 11:45hrs to register for the UK Oncology Forum (which has FREE registration and is CME accredited) please go to:
www.oncology-forum.co.uk/register

Best wishes
The UK Oncology Forum
PS please feel free to share with your colleagues

Latest News

By BOPA on 24th February 2026

BOPA Executive Committee Members and Subcommittee Co-chairs endorse and support Joseph Williams for the Election of the Royal College of Pharmacy English Pharmacy Advisory Councils

Dear BOPA Members As the Chair of the British Oncology Pharmacy Association (BOPA), I am writing to ask you to consider supporting Joseph Williams in the upcoming Royal Pharmaceutical Society English Pharmacy Advisory Council (currently called…

Read article
By BOPA Education & Training Subcommittee on 18th February 2026

Education and Training Webinar – Using ChatGPT & LLMs in Healthcare: A Short, Practical Introduction

Monday 23rd February 2026 at 12:00 GMT REGISTER for the Webinar HERE Available for both PAID members and FREE associates The BOPA Education and Training Subcommittee would like to invite you…

Read article
By BOPA Digital Subcommittee on 16th February 2026

BOPA Social Media & Communication Preferences Survey

Dear BOPA member, The BOPA digital subcommittee is conducting a short survey to better understand how pharmacy healthcare professionals working in oncology use social media and how they prefer to…

Read article
By BOPA E&T Subcommittee on 16th February 2026

Cancer Advanced and Consultant Pharmacist credentialing support series – First session

First session: Wednesday 25th February 3:30pm   BOPA are continuing their supportive webinar series for pharmacists who are credentialing as advanced and consultant pharmacists with the RPS.   Format: There…

Read article